journal article·2025-12-31Open access

Optimized PEGylated paclitaxel and 6-gingerol co-loaded liposomes induce G2/M phase arrest and apoptosis in MDA-MB-231 breast and A549 lung cancer cells

Priyadharshini Thangavelu, Kaavya Gunasekaran, Senthilkumar Periyathambi, Abeer Hashem, Nouf H. Alotaibi, Elsayed Fathi Abd_Allah, Rama Jayaraj, Naveen Kumar Kalagatur, Suja Samiappan

Abstract

The study aimed to optimize and develop novel PEGylated co-loaded nanoliposome entrapped with paclitaxel (PTX) and 6-gingerol (Gn) (PEG-Lipo-PTX-Gn) by response surface methodology (RSM) approach to prevent the diffusion and resistant-related issues of PTX in oncotherapy. Physiochemical characterization studies results revealed that the prepared PEG-Lipo-PTX-Gn attained optimum particle size, shape, charge, polydispersity index (PDI) as well as showed synergistic entrapment of PTX and Gn, sustained drug release, better colloidal stability and structural integrity. PEG-Lipo-PTX-Gn exhibited a noteworthy antiproliferative effect, apoptotic percentage and a higher proportion of G2/M cell cycle arrest in MDA-MB-231 and A549 cell lines. Meanwhile, no significant toxicity was observed in normal cell lines (HEK 293 kidney embryonic cells and L929 fibroblast cells). Another testament to its efficacy is the dramatic decline in Bcl-2 levels in the PEG-Lipo-PTX-Gn-treated group. Hence, optimized PEG-Lipo-PTX-Gn could be a promising novel approach in cancer treatment regimens.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics · Drug Transport and Resistance Mechanisms

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Biochemistry, Bharathiar University

Department of Veterinary Pharmacology and Toxicology, Veterinary College and Research Institute

Department of Botany and Microbiology, College of Science, King Saud University

Department of Chemistry, College of Science, King Saud University

Department of Plant Production, College of Food Science and Agriculture, King Saud University

Jindal Institute of Behavioral Sciences (JIBS), Jindal Global Institution of Eminence Deemed to be University

Director of Clinical Sciences, Northern Territory Institute of Research and Training

DRDO-BU-Centre for Life Sciences, Bharathiar University

Funding

King Saud University, Riyadh, Saudi Arabia

References (46)

Show source-provided references
1. 10.3389/fphar.2023.115730610.3389/fphar.2023.1157306 ↗
2. 10.1016/j.tins.2023.01.00310.1016/j.tins.2023.01.003 ↗
3. 10.18632/oncotarget.1672310.18632/oncotarget.16723 ↗
4. 10.5772/intechopen.109110.5772/intechopen.1091 ↗
5. 10.1038/s41586-022-04437-210.1038/s41586-022-04437-2 ↗
6. 10.2147/ott.s24164010.2147/ott.s241640 ↗
7. 10.1021/acs.jmedchem.2c0117510.1021/acs.jmedchem.2c01175 ↗
8. 10.3390/ijms2405437710.3390/ijms24054377 ↗
9. 10.3390/biom912078910.3390/biom9120789 ↗
10. 10.1093/rb/rbab01510.1093/rb/rbab015 ↗
11. 10.7759/cureus.5101110.7759/cureus.51011 ↗
12. 10.3389/fphar.2019.0161410.3389/fphar.2019.01614 ↗
13. 10.1155/2020/889645510.1155/2020/8896455 ↗
14. 10.3390/ijms23241576510.3390/ijms232415765 ↗
15. 10.1155/2015/14297910.1155/2015/142979 ↗
16. 10.1016/j.ram.2024.10.0010.1016/j.ram.2024.10.00 ↗
17. 10.3389/fnut.2022.82910110.3389/fnut.2022.829101 ↗
18. 10.3390/molecules2709269310.3390/molecules27092693 ↗
19. 10.1007/978-1-4939-6591-5_210.1007/978-1-4939-6591-5_2 ↗
20. 10.5530/ijper.53.2s.6310.5530/ijper.53.2s.63 ↗
21. 10.2147/ijn.s15774610.2147/ijn.s157746 ↗
22. 10.1007/978-1-61779-080-5_2010.1007/978-1-61779-080-5_20 ↗
23. 10.1016/0065-2571(84)90007-410.1016/0065-2571(84)90007-4 ↗
24. 10.1016/j.colsurfb.2015.02.04010.1016/j.colsurfb.2015.02.040 ↗
25. 10.1016/j.ijpharm.2017.11.00610.1016/j.ijpharm.2017.11.006 ↗
26. 10.3389/fonc.2023.109842910.3389/fonc.2023.1098429 ↗
27. 10.3109/10837450.2014.96532310.3109/10837450.2014.965323 ↗
28. 10.1016/j.colsurfb.2016.01.03210.1016/j.colsurfb.2016.01.032 ↗
29. 10.22038/nmj.2025.78286.191410.22038/nmj.2025.78286.1914 ↗
30. 10.3109/08982104.2015.107017410.3109/08982104.2015.1070174 ↗
31. 10.1155/2014/42429310.1155/2014/424293 ↗
32. 10.1186/s13065-018-0482-610.1186/s13065-018-0482-6 ↗
33. 10.3390/cancers1315374910.3390/cancers13153749 ↗
34. 10.1080/10717544.2016.124792510.1080/10717544.2016.1247925 ↗
35. 10.1002/cpmc.9010.1002/cpmc.90 ↗
36. 10.1016/j.heliyon.2024.e3565110.1016/j.heliyon.2024.e35651 ↗
37. 10.3390/pharmaceutics1308131310.3390/pharmaceutics13081313 ↗
38. 10.3390/jpm1108077110.3390/jpm11080771 ↗
39. 10.2147/ijn.s28944310.2147/ijn.s289443 ↗
40. 10.3390/pharmaceutics1402027210.3390/pharmaceutics14020272 ↗
41. 10.2217/pgs.15.12310.2217/pgs.15.123 ↗
42. 10.1016/j.ejpb.2017.02.02010.1016/j.ejpb.2017.02.020 ↗
43. 10.1039/c7ra01100h10.1039/c7ra01100h ↗
44. 10.1016/j.heliyon.2024.e3708910.1016/j.heliyon.2024.e37089 ↗
45. 10.1080/15384047.2019.163867810.1080/15384047.2019.1638678 ↗
46. 10.1038/s41598-021-02503-910.1038/s41598-021-02503-9 ↗